Cargando…
Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas
OBJECTIVES: Lung carcinoids and atypical hamartomas may be difficult to differentiate but require different treatment. The aim was to differentiate these tumors using contrast-enhanced CT semantic and radiomics criteria. METHODS: Between November 2009 and June 2020, consecutives patient operated for...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509085/ https://www.ncbi.nlm.nih.gov/pubmed/37726504 http://dx.doi.org/10.1186/s13244-023-01484-9 |
_version_ | 1785107665515446272 |
---|---|
author | Habert, Paul Decoux, Antoine Chermati, Lilia Gibault, Laure Thomas, Pascal Varoquaux, Arthur Le Pimpec-Barthes, Françoise Arnoux, Armelle Juquel, Loïc Chaumoitre, Kathia Garcia, Stéphane Gaubert, Jean-Yves Duron, Loïc Fournier, Laure |
author_facet | Habert, Paul Decoux, Antoine Chermati, Lilia Gibault, Laure Thomas, Pascal Varoquaux, Arthur Le Pimpec-Barthes, Françoise Arnoux, Armelle Juquel, Loïc Chaumoitre, Kathia Garcia, Stéphane Gaubert, Jean-Yves Duron, Loïc Fournier, Laure |
author_sort | Habert, Paul |
collection | PubMed |
description | OBJECTIVES: Lung carcinoids and atypical hamartomas may be difficult to differentiate but require different treatment. The aim was to differentiate these tumors using contrast-enhanced CT semantic and radiomics criteria. METHODS: Between November 2009 and June 2020, consecutives patient operated for hamartomas or carcinoids with contrast-enhanced chest-CT were retrospectively reviewed. Semantic criteria were recorded and radiomics features were extracted from 3D segmentations using Pyradiomics. Reproducible and non-redundant radiomics features were used to training a random forest algorithm with cross-validation. A validation-set from another institution was used to evaluate of the radiomics signature, the 3D ‘median’ attenuation feature (3D-median) alone and the mean value from 2D-ROIs. RESULTS: Seventy-three patients (median 58 years [43‒70]) were analyzed (16 hamartomas; 57 carcinoids). The radiomics signature predicted hamartomas vs carcinoids on the external dataset (22 hamartomas; 32 carcinoids) with an AUC = 0.76. The 3D-median was the most important in the model. Density thresholds < 10 HU to predict hamartoma and > 60 HU to predict carcinoids were chosen for their high specificity > 0.90. On the external dataset, sensitivity and specificity of the 3D-median and 2D-ROIs were, respectively, 0.23, 1.00 and 0.13, 1.00 < 10 HU; 0.63, 0.95 and 0.69, 0.91 > 60 HU. The 3D-median was more reproducible than 2D-ROIs (ICC = 0.97 95% CI [0.95‒0.99]; bias: 3 ± 7 HU limits of agreement (LoA) [− 10‒16] vs. ICC = 0.90 95% CI [0.85‒0.94]; bias: − 0.7 ± 21 HU LoA [− 4‒40], respectively). CONCLUSIONS: A radiomics signature can distinguish hamartomas from carcinoids with an AUC = 0.76. Median density < 10 HU and > 60 HU on 3D or 2D-ROIs may be useful in clinical practice to diagnose these tumors with confidence, but 3D is more reproducible. CRITICAL RELEVANCE STATEMENT: Radiomic features help to identify the most discriminating imaging signs using random forest. ‘Median’ attenuation value (Hounsfield units), extracted from 3D-segmentations on contrast-enhanced chest-CTs, could distinguish carcinoids from atypical hamartomas (AUC = 0.85), was reproducible (ICC = 0.97), and generalized to an external dataset. KEY POINTS: • 3D-‘Median’ was the best feature to differentiate carcinoids from atypical hamartomas (AUC = 0.85). • 3D-‘Median’ feature is reproducible (ICC = 0.97) and was generalized to an external dataset. • Radiomics signature from 3D-segmentations differentiated carcinoids from atypical hamartomas with an AUC = 0.76. • 2D-ROI value reached similar performance to 3D-‘median’ but was less reproducible (ICC = 0.90). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01484-9. |
format | Online Article Text |
id | pubmed-10509085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-105090852023-09-21 Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas Habert, Paul Decoux, Antoine Chermati, Lilia Gibault, Laure Thomas, Pascal Varoquaux, Arthur Le Pimpec-Barthes, Françoise Arnoux, Armelle Juquel, Loïc Chaumoitre, Kathia Garcia, Stéphane Gaubert, Jean-Yves Duron, Loïc Fournier, Laure Insights Imaging Original Article OBJECTIVES: Lung carcinoids and atypical hamartomas may be difficult to differentiate but require different treatment. The aim was to differentiate these tumors using contrast-enhanced CT semantic and radiomics criteria. METHODS: Between November 2009 and June 2020, consecutives patient operated for hamartomas or carcinoids with contrast-enhanced chest-CT were retrospectively reviewed. Semantic criteria were recorded and radiomics features were extracted from 3D segmentations using Pyradiomics. Reproducible and non-redundant radiomics features were used to training a random forest algorithm with cross-validation. A validation-set from another institution was used to evaluate of the radiomics signature, the 3D ‘median’ attenuation feature (3D-median) alone and the mean value from 2D-ROIs. RESULTS: Seventy-three patients (median 58 years [43‒70]) were analyzed (16 hamartomas; 57 carcinoids). The radiomics signature predicted hamartomas vs carcinoids on the external dataset (22 hamartomas; 32 carcinoids) with an AUC = 0.76. The 3D-median was the most important in the model. Density thresholds < 10 HU to predict hamartoma and > 60 HU to predict carcinoids were chosen for their high specificity > 0.90. On the external dataset, sensitivity and specificity of the 3D-median and 2D-ROIs were, respectively, 0.23, 1.00 and 0.13, 1.00 < 10 HU; 0.63, 0.95 and 0.69, 0.91 > 60 HU. The 3D-median was more reproducible than 2D-ROIs (ICC = 0.97 95% CI [0.95‒0.99]; bias: 3 ± 7 HU limits of agreement (LoA) [− 10‒16] vs. ICC = 0.90 95% CI [0.85‒0.94]; bias: − 0.7 ± 21 HU LoA [− 4‒40], respectively). CONCLUSIONS: A radiomics signature can distinguish hamartomas from carcinoids with an AUC = 0.76. Median density < 10 HU and > 60 HU on 3D or 2D-ROIs may be useful in clinical practice to diagnose these tumors with confidence, but 3D is more reproducible. CRITICAL RELEVANCE STATEMENT: Radiomic features help to identify the most discriminating imaging signs using random forest. ‘Median’ attenuation value (Hounsfield units), extracted from 3D-segmentations on contrast-enhanced chest-CTs, could distinguish carcinoids from atypical hamartomas (AUC = 0.85), was reproducible (ICC = 0.97), and generalized to an external dataset. KEY POINTS: • 3D-‘Median’ was the best feature to differentiate carcinoids from atypical hamartomas (AUC = 0.85). • 3D-‘Median’ feature is reproducible (ICC = 0.97) and was generalized to an external dataset. • Radiomics signature from 3D-segmentations differentiated carcinoids from atypical hamartomas with an AUC = 0.76. • 2D-ROI value reached similar performance to 3D-‘median’ but was less reproducible (ICC = 0.90). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13244-023-01484-9. Springer Vienna 2023-09-19 /pmc/articles/PMC10509085/ /pubmed/37726504 http://dx.doi.org/10.1186/s13244-023-01484-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Habert, Paul Decoux, Antoine Chermati, Lilia Gibault, Laure Thomas, Pascal Varoquaux, Arthur Le Pimpec-Barthes, Françoise Arnoux, Armelle Juquel, Loïc Chaumoitre, Kathia Garcia, Stéphane Gaubert, Jean-Yves Duron, Loïc Fournier, Laure Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas |
title | Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas |
title_full | Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas |
title_fullStr | Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas |
title_full_unstemmed | Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas |
title_short | Best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas |
title_sort | best imaging signs identified by radiomics could outperform the model: application to differentiating lung carcinoid tumors from atypical hamartomas |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509085/ https://www.ncbi.nlm.nih.gov/pubmed/37726504 http://dx.doi.org/10.1186/s13244-023-01484-9 |
work_keys_str_mv | AT habertpaul bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT decouxantoine bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT chermatililia bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT gibaultlaure bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT thomaspascal bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT varoquauxarthur bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT lepimpecbarthesfrancoise bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT arnouxarmelle bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT juquelloic bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT chaumoitrekathia bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT garciastephane bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT gaubertjeanyves bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT duronloic bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas AT fournierlaure bestimagingsignsidentifiedbyradiomicscouldoutperformthemodelapplicationtodifferentiatinglungcarcinoidtumorsfromatypicalhamartomas |